| P2093 | author name string | S Parthasarathy | |
| | W R Taylor | |
| | J G Kim | |
| P2860 | cites work | Generation and characterization of a polyclonal antipeptide antibody to human glycodelin | Q41052814 |
| | Malondialdehyde-altered protein occurs in atheroma of Watanabe heritable hyperlipidemic rabbits | Q43652291 |
| | Distribution of oxidation specific lipid-protein adducts and apolipoprotein B in atherosclerotic lesions of varying severity from WHHL rabbits | Q46491747 |
| | Immunostaining of human autopsy aortas with antibodies to modified apolipoprotein B and apoprotein(a) | Q72100957 |
| | Generation of a polyclonal antibody against lipid peroxide-modified proteins | Q73451651 |
| | Immunohistochemical demonstration of enzymatically modified human LDL and its colocalization with the terminal complement complex in the early atherosclerotic lesion | Q74351422 |
| | Structural Analysis of the Oligosaccharides Derived from Glycodelin, a Human Glycoprotein with Potent Immunosuppressive and Contraceptive Activities | Q28291747 |
| | Low density lipoprotein undergoes oxidative modification in vivo | Q33838672 |
| | Evidence for a concerted reaction between lipid hydroperoxides and polypeptides | Q37288702 |
| | Presence of hypochlorite-modified proteins in human atherosclerotic lesions | Q37353371 |
| | Generation, characterization, and histochemical application of monoclonal antibodies selectively recognizing oxidatively modified apoB-containing serum lipoproteins | Q38295835 |
| | Localization patterns of plasma apolipoproteins in human atherosclerotic lesions | Q39942261 |
| | Malondialdehyde-modified low density lipoproteins in patients with atherosclerotic disease | Q40344004 |
| P433 | issue | 2 | |
| P921 | main subject | atherosclerosis | Q12252367 |
| P304 | page(s) | 335-340 | |
| P577 | publication date | 1999-04-01 | |
| P1433 | published in | Atherosclerosis | Q4813570 |
| P1476 | title | Demonstration of the presence of lipid peroxide-modified proteins in human atherosclerotic lesions using a novel lipid peroxide-modified anti-peptide antibody. | |
| P478 | volume | 143 | |